halofenate has been researched along with Angor Pectoris in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aronow, WS; Harding, PR; Khemka, M; Khursheed, M; Nelson, WH; Pagano, J; Papageorge's, NP; Vangrow, JS | 1 |
1 trial(s) available for halofenate and Angor Pectoris
| Article | Year |
|---|---|
Halofenate, serum lipids, and exercise performance in coronary heart disease.
Topics: Adult; Aged; Angina Pectoris; Cholesterol; Clinical Trials as Topic; Coronary Disease; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Physical Exertion; Time Factors; Triglycerides | 1974 |